Profile of antiphospholipid antibodies and complement system in COVID-19 patients of different severity
COVID-19, a severe acute respiratory syndrome caused by SARS-CoV-2, may predispose to thrombotic events, especially when combined with antiphospholipid antibodies (aPL). However, there are limited data on prevalence and antigenic specificity of aPL in COVID-19. Complement activation is assumed to pl...
Main Authors: | N. V. Dolgushina, I. V. Menzhinskaya, O. S. Beznoshchenko, S. M. Mullabayeva, E. A. Gorodnova, L. V. Krechetova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2022-04-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2465 |
Similar Items
-
Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
by: Bećarević Mirjana B., et al.
Published: (2022-01-01) -
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
by: Cecilia Nalli, et al.
Published: (2021-06-01) -
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
by: Ariadna Anunciación-Llunell, et al.
Published: (2022-10-01) -
Catastrophic antiphospholipid syndrome: a narrative review
by: Maria Giulia Tinti, et al.
Published: (2019-12-01) -
Antiphospholipid antibodies in forty young patients with stroke
by: Khudhair A. AL- Khalissi, et al.
Published: (2015-07-01)